AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.090
-0.140 (-6.28%)
At close: Apr 1, 2025, 4:00 PM
2.190
+0.100 (4.78%)
After-hours: Apr 1, 2025, 7:57 PM EDT

AbCellera Biologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-162.86-146.4158.52153.46118.92
Upgrade
Depreciation & Amortization
6530.8924.717.255.27
Upgrade
Asset Writedown & Restructuring Costs
32-8.4--
Upgrade
Stock-Based Compensation
67.5864.1849.4830.658.4
Upgrade
Other Operating Activities
-84.44-5.786.431.556.81
Upgrade
Change in Accounts Receivable
-75.12-36.66106.4622.48-203.02
Upgrade
Change in Accounts Payable
10.64-15.1-2.09-3.246.6
Upgrade
Change in Unearned Revenue
26.0425.5515.4539.3415.05
Upgrade
Change in Income Taxes
6.6530.46-88.61-13.5336.41
Upgrade
Change in Other Net Operating Assets
5.958.98-1.38-3.3828.26
Upgrade
Operating Cash Flow
-108.56-43.88277.36244.5822.69
Upgrade
Operating Cash Flow Growth
--13.40%977.94%742.24%
Upgrade
Capital Expenditures
-78.4-76.95-70.66-58.45-9.67
Upgrade
Cash Acquisitions
----11.46-87.64
Upgrade
Sale (Purchase) of Intangibles
--0.56-2--5
Upgrade
Investment in Securities
164.1-168.91-296.4-294.96-17.46
Upgrade
Other Investing Activities
35.7125.3116.4332.62-
Upgrade
Investing Cash Flow
121.41-221.11-352.63-332.25-119.78
Upgrade
Long-Term Debt Issued
13.511.592.765.4989.99
Upgrade
Total Debt Issued
13.511.592.765.4989.99
Upgrade
Long-Term Debt Repaid
-----19.94
Upgrade
Total Debt Repaid
-----19.94
Upgrade
Net Debt Issued (Repaid)
13.511.592.765.4970.05
Upgrade
Issuance of Common Stock
----539.33
Upgrade
Other Financing Activities
-0.73-1.23-4.38-9.37-0.39
Upgrade
Financing Cash Flow
12.7710.36-1.63-3.89683.65
Upgrade
Foreign Exchange Rate Adjustments
-2.620.59-9.6-1.43-
Upgrade
Net Cash Flow
23.01-254.04-86.49-92.97586.56
Upgrade
Free Cash Flow
-186.95-120.82206.7186.1313.02
Upgrade
Free Cash Flow Growth
--11.05%1329.91%-
Upgrade
Free Cash Flow Margin
-648.40%-317.75%42.58%49.61%5.58%
Upgrade
Free Cash Flow Per Share
-0.64-0.420.660.580.05
Upgrade
Levered Free Cash Flow
-177.77-102.96205.62143.8-24.06
Upgrade
Unlevered Free Cash Flow
-177.77-102.96205.62143.8-19.8
Upgrade
Change in Net Working Capital
55.22-27.72-63.53-26.6116.32
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q